3.6 Arterial thrombosis and anti-platelet drugs Flashcards
stable atherosclerotic plaques characteristics
hyalinised
calcified
stable angina, intermittent claudication
unstable atherosclerotic plaques
plaques rupture, platelets recruited, cause acute thrombosis
sudden onset of symptoms
unstable angina or MI, stroke - acute organ ischaemia and infarction
what is the sequence of events in arterial thrombosis?
plaque rupture in high pressure environment
platelets adhere
exposed endothemlium binds von willebrand and platelet
activation of platelets- granules that activate coagulation and develop platelet plug
membrane glycoproteins cause platelet aggrestion - surface glycoprotein 1b (surfaces), and IIb/IIIa- stick to each other
RF that damage endothelium, increase foamy macrophage and platelet activation
HTN
smoking
high cholesterol
diabetes
reduce the risk by reducing these, and giving anti-platelet drug
what chemicals do platelets secrete that lead to aggregation of platelets?
ADP
thromboxane A2
thrombin
what do platelets bind on exposed endothelium?
subendothelial collagen is adhered to by:
- glycoprotein 1b
- von willebrand factor
what do platelets use to bind each other and fibrinogen?
GP IIb
GP IIIa
what is the effect of protein shape changing in activation?
expose more phospholipid
what role does aspirin play in arterial thrombosis?
aspirin inhibits COX, enzyme that eventually produces thromboxane A2
-platelet agonist released from platelet granules on activation
actually COX inhibition prevents arachadonic acid from turning into prostaglandin G2/H2
a second enzyme- thromboxane synthase actually turns prostagland in G2/H2 –> thromboxane A2 which causes platelet activation and aggregation
side effects of aspirin
bleeding
blocks prostaglandins- GI ulceration, bronchospasm
contraindicated in asthma
what is the mechanism for clopidogrel and prasugrel?
ADP receptor antagonists
clopidogrel is more effective
reduced incidence of peptic ulceration
what is the mechanism of dipyridamole?
phosphodisterase inhibitor
-reduced cAMMP that is a second messenger in platelet activation
abcixamab - what is it, what does it do?
abciximab is a GP IIb/IIIa inhibitor, and it prevents platelet aggregation
used in cardiac surgery, angioplasty, potent.
what should be done to antiplatelet drugs prior to surgery?
stop antiplatelet agents 7 days prior to elective operations
-antiplatelet drugs tend to affect platelet function for their 7-10 day lifespan
if there is serious bleeding- reverse with platelet transfusion